Regulatory Focus |
FDA Warns Drugmaker Over Opioid Marketing Materials
Regulatory Focus According to FDA, marketing materials for ConZip aimed at a professional audience and distributed by Vertical Pharmaceuticals, which holds an exclusive license to market and sell the drug in the US, completely left out risk information and key details ... |
September 05, 2017 at 06:22PM | marketing - Google News
FDA Warns Drugmaker Over Opioid Marketing Materials - Regulatory Focus
marketing - Google News
Nenhum comentário:
Postar um comentário